Case Study: a Japanese midsize global pharmaceutical and biotechnology company achieves 100% on-time submissions and over 50% cost savings with FREYR

a Japanese midsize global pharmaceutical and biotechnology company achieves 100% on-time submissions with FREYR

A Japanese midsize global pharmaceutical and biotechnology company faced resource instability and process inefficiencies in managing its US and Canadian regulatory submissions. To address these challenges, the company partnered with FREYR for comprehensive publishing support and process optimization.

FREYR implemented a scalable hybrid staffing model and established standardized publishing best practices. This solution enabled the client to achieve 100% on-time submissions, realize over 50% cost savings, and record zero Health Authority rejections, transforming their regulatory operations for key global markets.